Christopher John Yarnold
14Patents
4h-index
56Co-inventors
63Inventor score
Filing activity: Jan 6, 2000 → Dec 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6573247B1 | Anti-viral pyrimidine nucleoside analogues | Chemistry; Metallurgy | 32 | Expired |
| US8536186B2 | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 7 | Active |
| US9145373B2 | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US10364239B2 | Ferroportin inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10738041B2 | Ferroportin inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9102688B2 | Sulfonaminoquinoline hepcidin antagonists | Chemistry; Metallurgy | 1 | Active |
| US8946197B2 | Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11180479B2 | Antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US11066399B2 | Ferroportin inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US7915304B2 | Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT | Chemistry; Metallurgy | 0 | Active |
| US8691824B2 | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11091428B2 | Antiviral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8592430B2 | Quinazolin-oxime derivatives as Hsp90 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11001579B2 | Ferroportin inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.